prov:value
| - AG, Virometix and NANOTION.Organisations highlighted a number of opportunities to UK businesses in oncology, neurodegenerative diseases, fertility and endocrinology, diabetes, intracellular and blood brain barrier targeting, chemical biology, stem cell(s) and related technologies, cardiovascular disorders, neurological disorders, such as Alzheimer's disease and ageing.
|